STOCK TITAN

LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

LifeVantage (Nasdaq: LFVN) has launched its patent-pending MindBody GLP-1 System™ in the U.S., a dual-product solution designed to balance hunger hormones and support sustainable weight management. The system includes MB Core™ and MB Enhance™, which together increase natural GLP-1 production by an average of 140%.

Clinical trials showed that the system helped participants lose up to 27% of visceral fat and 5% of total body fat while maintaining muscle. The product launch at Market Connect in Kansas City met with high demand, with on-site products selling out quickly and e-commerce sales exceeding forecasts.

The MindBody GLP-1 System™ works by increasing GLP-1 production, activating GLP-1 receptor sites, and reducing the activity of enzymes that break down GLP-1. This approach aims to provide a comprehensive solution for long-term weight management and overall wellness.

LifeVantage (Nasdaq: LFVN) ha lanciato il suo sistema brevettato MindBody GLP-1 System™ negli Stati Uniti, una soluzione a doppio prodotto progettata per bilanciare gli ormoni della fame e supportare una gestione del peso sostenibile. Il sistema include MB Core™ e MB Enhance™, che insieme aumentano la produzione naturale di GLP-1 del 140% in media.

Gli studi clinici hanno dimostrato che il sistema ha aiutato i partecipanti a perdere fino al 27% di grasso viscerale e il 5% di grasso corporeo totale mantenendo la massa muscolare. Il lancio del prodotto a Market Connect a Kansas City ha incontrato un'alta domanda, con i prodotti in loco esauriti rapidamente e le vendite e-commerce superiori alle previsioni.

Il sistema MindBody GLP-1™ funziona aumentando la produzione di GLP-1, attivando i siti recettoriali del GLP-1 e riducendo l'attività degli enzimi che degradano il GLP-1. Questo approccio mira a fornire una soluzione completa per la gestione del peso a lungo termine e il benessere generale.

LifeVantage (Nasdaq: LFVN) ha lanzado su sistema en proceso de patente MindBody GLP-1 System™ en los EE. UU., una solución de doble producto diseñada para equilibrar las hormonas del hambre y apoyar una gestión sostenible del peso. El sistema incluye MB Core™ y MB Enhance™, que juntos incrementan la producción natural de GLP-1 en un promedio del 140%.

Los ensayos clínicos mostraron que el sistema ayudó a los participantes a perder hasta un 27% de grasa visceral y un 5% de grasa corporal total mientras mantenían masa muscular. El lanzamiento del producto en Market Connect en Kansas City contó con alta demanda, con productos en el sitio vendiéndose rápidamente y ventas en línea superando las previsiones.

El sistema MindBody GLP-1™ funciona aumentando la producción de GLP-1, activando los sitios de los receptores de GLP-1 y reduciendo la actividad de las enzimas que descomponen el GLP-1. Este enfoque tiene como objetivo proporcionar una solución integral para la gestión del peso a largo plazo y el bienestar general.

LifeVantage (Nasdaq: LFVN)는 미국에서 특허 출원 중인 MindBody GLP-1 System™을 출시했습니다. 이는 배고픔 호르몬을 조절하고 지속 가능한 체중 관리를 지원하도록 설계된 이중 제품 솔루션입니다. 이 시스템에는 MB Core™MB Enhance™가 포함되어 있으며, 둘을 함께 사용하면 평균 140%의 자연 GLP-1 생산이 증가합니다.

임상 시험 결과에 따르면, 이 시스템은 참가자들이 내장 지방을 최대 27%, 총 체지방을 5% 줄이는 데 도움을 주었으며 근육량은 유지할 수 있었습니다. 캔자스시티에서 열린 Market Connect에서의 제품 출시는 높은 수요를 보였으며, 현장에서 상품이 빠르게 매진되고 전자상거래 매출이 예상을 초과했습니다.

MindBody GLP-1 System™은 GLP-1 생산을 증가시키고, GLP-1 수용체 부위를 활성화하며, GLP-1을 분해하는 효소의 활동을 줄이는 방식으로 작동합니다. 이 접근법은 장기적인 체중 관리와 전반적인 웰빙을 위한 포괄적인 솔루션을 제공하는 것을 목표로 하고 있습니다.

LifeVantage (Nasdaq: LFVN) a lancé son système en instance de brevet MindBody GLP-1 System™ aux États-Unis, une solution à double produit conçue pour équilibrer les hormones de la faim et soutenir une gestion durable du poids. Le système comprend MB Core™ et MB Enhance™, qui à eux deux augmentent la production naturelle de GLP-1 de 140% en moyenne.

Des essais cliniques ont montré que le système a aidé les participants à perdre jusqu'à 27% de graisse viscérale et 5% de graisse corporelle totale tout en maintenant la masse musculaire. Le lancement du produit lors de Market Connect à Kansas City a suscité une forte demande, avec des produits sur place se vendant rapidement et les ventes en ligne dépassant les prévisions.

Le système MindBody GLP-1™ fonctionne en augmentant la production de GLP-1, en activant les sites récepteurs de GLP-1 et en réduisant l'activité des enzymes qui décomposent le GLP-1. Cette approche vise à fournir une solution complète pour la gestion du poids à long terme et le bien-être général.

LifeVantage (Nasdaq: LFVN) hat sein patentiertes MindBody GLP-1 System™ in den USA eingeführt, eine duale Produktlösung, die entwickelt wurde, um Hungerhormone ins Gleichgewicht zu bringen und eine nachhaltige Gewichtsregulation zu unterstützen. Das System umfasst MB Core™ und MB Enhance™, die zusammen die natürliche GLP-1-Produktion im Durchschnitt um 140% steigern.

Klinische Studien haben gezeigt, dass das System den Teilnehmern half, bis zu 27% viszerales Fett und 5% Gesamtkörperfett zu verlieren, während die Muskelmasse erhalten blieb. Der Produkteinführungs-Event bei Market Connect in Kansas City traf auf hohe Nachfrage, wobei die vor Ort angebotenen Produkte schnell ausverkauft waren und der Online-Verkauf die Prognosen übertraf.

Das MindBody GLP-1 System™ funktioniert, indem es die GLP-1-Produktion erhöht, die GLP-1-Rezeptorstellen aktiviert und die Aktivität der Enzyme reduziert, die GLP-1 abbauen. Dieser Ansatz zielt darauf ab, eine umfassende Lösung für das langfristige Gewichtsmanagement und das allgemeine Wohlbefinden bereitzustellen.

Positive
  • Launch of new MindBody GLP-1 System™ with clinically proven results
  • High demand for the product, with sell-outs at launch event
  • E-commerce sales exceeding forecast
  • Clinical trials showing up to 27% visceral fat loss and 5% total body fat loss
  • Increased natural GLP-1 production by an average of 140%
Negative
  • None.

Insights

The launch of LifeVantage's MindBody GLP-1 System™ represents a significant development in the natural weight management market. The system's ability to increase GLP-1 production by 140% on average is impressive, potentially offering a competitive edge in the crowded wellness industry.

Clinical trial results showing up to 27% visceral fat loss and 5% total body fat reduction while maintaining muscle mass are noteworthy. These outcomes, if replicated in broader use, could position LifeVantage as a strong player in the weight management sector.

The dual-product approach, combining MB Core™ and MB Enhance™, demonstrates a sophisticated understanding of GLP-1 activation and metabolism. This holistic strategy, addressing both GLP-1 production and its breakdown, could lead to more sustained results compared to single-product solutions.

However, investors should note that the weight loss market is highly competitive and subject to regulatory scrutiny. The success of this product will depend on its ability to deliver consistent results and navigate potential regulatory challenges. The initial high demand and sell-out at the Market Connect event are positive indicators, but long-term success will hinge on broader market acceptance and sustained sales performance.

The launch of the MindBody GLP-1 System™ could be a game-changer for LifeVantage's financial outlook. With a current market cap of $150,994,028, this product has the potential to significantly impact the company's revenue stream.

The immediate sell-out at the Market Connect event and the need for additional inventory suggest strong initial demand. This could translate into a substantial boost in short-term sales figures. Moreover, the e-commerce sales exceeding forecasts indicate broader market interest beyond the company's consultant network.

Investors should pay close attention to the upcoming quarterly reports to gauge the system's impact on revenue. If the product maintains its momentum, it could lead to improved profit margins and potentially drive up the stock price.

However, it's important to consider the costs associated with scaling production to meet demand and the marketing expenses required to maintain growth. The success of this product could also attract competitors, potentially affecting long-term market share and profitability.

Overall, this launch represents a positive development for LifeVantage, with the potential to enhance its market position in the wellness industry and drive financial growth.

Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger Hormones and Reduce Cravings, Supporting Sustainable Weight and Visceral Fat Loss While Maintaining Muscle ‡Ω

SALT LAKE CITY, Oct. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is excited to announce the U.S. launch of its patent-pending MindBody GLP-1 System™, a dual-product solution designed to balance hunger hormones, build healthier habits, and help individuals reach and maintain their ideal weight. This revolutionary system includes MB Core™ and MB Enhance™, which work together to activate natural GLP-1 production by 140% on average. Clinical trials also found that the new System helped participants lose up to 27% of visceral fat and 5% of total body fat while maintaining muscle. *‡Ω

The new System was revealed at Market Connect held October 11-12, in Kansas City. Event attendees sold out on-site product within hours and additional inventory was brought in to meet the high demand. Demand was apparent across the market as well, with e-commerce sales also exceeding forecast.

“Our innovative MindBody GLP-1 System™ naturally activates GLP-1 production, providing consumers with a demonstrable weight management solution,” said Steve Fife, President and CEO. “It’s something people are searching for and as the Activation company, LifeVantage is uniquely positioned to deliver. We are excited for our Consultants to be able to offer such a transformational product to reach those looking for the best natural solution on the market.”

Turn Up GLP-1. Turn Down Food Noise.*

GLP-1, a hormone naturally produced in the large intestine, is essential for regulating appetite and maintaining healthy blood sugar levels. It promotes feelings of fullness, slows gastric emptying, and helps reduce overeating by communicating to the brain via the gut-brain axis. However, natural GLP-1 production can be affected by factors such as aging, genetics, and lifestyle, making weight management more challenging over time.*

LifeVantage’s MindBody GLP-1 System™ increases GLP-1 production by 140%, increases activation of GLP-1 receptor sites by 53%, and reduces the activity of enzymes that break down GLP-1 by 38%§, providing a comprehensive solution for sustainable weight loss and overall wellness. This system represents a shift from traditional weight management methods, focusing on long-term lifestyle changes and your relationship with food.

“The MindBody GLP-1 System™ represents the culmination of years of research into the synergistic effects of natural ingredients on appetite and metabolism,” said Lisa Barnes, Vice President of Research and Development and Regulatory at LifeVantage. “We’ve discovered how specific botanical extracts and fibers can work together to activate GLP-1, creating a powerful system that supports sustainable weight loss and fosters a healthier relationship with food—freeing you to build the life you have always envisioned. It’s incredible when you see the results people are experiencing.” *

Dual Activation for Total Transformation

The MindBody GLP-1 System™, combined with an active lifestyle, promotes weight loss, enhances body composition, and fosters a healthier relationship with food. This holistic approach supports visible and tangible results.*

  • MB Core™: A blend including Acacia, Lemon Bioflavonoids, Berberine, Hesperidin, Eggplant, and Chromium that activates GLP-1 in specialized L-cells, promoting fullness via the gut-brain axis. It decreases cravings, slows gastric emptying, and balances key hunger hormones. MB Core™ also inhibits DPP-4, an enzyme that breaks down GLP-1, ensuring prolonged effectiveness.*
  • MB Enhance™: This product combines resistant starches and fibers, including Potato, Tapioca, that ferment in the large intestine. These fibers act as prebiotics, supporting gut health and priming L-cells for GLP-1 production. MB Enhance™ provides 48% of daily dietary fiber with a light vanilla flavor that compliments smoothies and other beverages.*

Market Connect in Kansas City

In addition to the product reveal, Market Connect featured exclusive Consultant business training, with a focus on the new commission bonuses and latest enhancements to the Evolve Compensation Plan going live November 1. Several Consultant experience enhancements were also announced including a new feature that allows you to build a suggested shopping cart for a new Consultant joining LifeVantage.

“Our MindBody GLP-1 System™ is poised to change the way consumers think about weight management. We’re purposefully helping people move away from short-term losses and yo-yo diets and into a sustainable, healthy lifestyle by activating GLP-1 naturally,” said Steve Fife, CEO of LifeVantage. “Our Consultants are able to use this incredible System and business opportunity to change the lives of others and create a pathway to a brighter future, including improved health and supplemental income.”

For more information about LifeVantage and its innovative MindBody GLP-1 System™ visit: https://www.lifevantage.com/us-en.

About LifeVantage Corporation

LifeVantage Corporation (Nasdaq: LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our products work with your unique biology and help your body make what it needs to optimize cellular function—just as nature intended. LifeVantage owns the identification, research, development, formulation, and sale of advanced nutrigenomic activators. The line of scientifically validated dietary supplements includes the flagship Protandim® family of products, TrueScience® Liquid Collagen, the newest MindBody GLP-1 System™, Activation-supporting nutrients such as Omega, D3+, and the AM/PM System, as well as AXIO® nootropic energy drink mixes, the full TrueScience® line of skin and hair care products, and Petandim®, a pet supplement formulated to combat oxidative stress in dogs. Our independent Consultants sell our products to Customers and share the business opportunity with entrepreneurs seeking to begin their own business. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.

Public Relations Contact:
Jennifer Rumble, CerconeBrownCompany
(704) 923-6378
jrumble@cerconebrown.com

Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
§Results based on a cell culture study on active ingredient blends in the MindBody GLP-1 System.
‡Results may vary. Typical weight loss using this product in a 12-week weight management program is 1–2 pounds per week. This product should be used in conjunction with a healthy diet and regular exercise. Consult with a healthcare provider before starting any weight loss program. 
Ω Results based on a randomized 12-week human clinical study. 


FAQ

What is LifeVantage's new MindBody GLP-1 System™ and how does it work?

LifeVantage's MindBody GLP-1 System™ is a dual-product solution designed to balance hunger hormones and support sustainable weight management. It includes MB Core™ and MB Enhance™, which work together to increase natural GLP-1 production by an average of 140%, activate GLP-1 receptor sites, and reduce the activity of enzymes that break down GLP-1.

What results were observed in clinical trials for LifeVantage's MindBody GLP-1 System™?

Clinical trials of LifeVantage's MindBody GLP-1 System™ showed that participants lost up to 27% of visceral fat and 5% of total body fat while maintaining muscle mass.

How was the launch of LifeVantage's MindBody GLP-1 System™ received?

The launch of LifeVantage's MindBody GLP-1 System™ was met with high demand. On-site products sold out quickly at the Market Connect event in Kansas City, and e-commerce sales exceeded forecasts.

What are the components of LifeVantage's MindBody GLP-1 System™?

LifeVantage's MindBody GLP-1 System™ consists of two products: MB Core™, which activates GLP-1 in specialized L-cells, and MB Enhance™, which combines resistant starches and fibers to support gut health and prime L-cells for GLP-1 production.

Lifevantage Corporation

NASDAQ:LFVN

LFVN Rankings

LFVN Latest News

LFVN Stock Data

169.09M
12.53M
16.87%
30.47%
1.85%
Packaged Foods
Pharmaceutical Preparations
Link
United States of America
LEHI